Skin science article
Palmitoyl Tetrapeptide-7 Dosing, Need to Know Information, Safety, Stacks, Dosing Calculator and more!
How much do I take? Is this right for me? How do I use it? Is it safe? How do I know it's working? Compound Profile Scientific & Efficacy Data C34H62N8O7 Molecular Formula 694.9 Da Molecular Weight Susceptible to enzymatic degradation; palmitoyl anchor reduces
How much do I take?
Is this right for me?
How do I use it?
Is it safe?
How do I know it's working?
Compound Profile
Scientific & Efficacy Data
C34H62N8O7
Molecular Formula
694.9 Da
Molecular Weight
Susceptible to enzymatic degradation; palmitoyl anchor reduces proteolytic cleavage rate compared to unmodified peptide
Half-Life
Enhanced topical penetration via palmitoyl lipid modification enabling membrane interaction and dermal delivery
Bioavailability
221227-05-0
CAS #
10078408
PubChem ID ↗
Developed By · 2005
Sederma research team
Sederma S.A. (part of Croda International)
Primary Benefits
Directly reduces IL-6 secretion in keratinocytes and fibroblasts, addressing the chronic inflammation that accelerates skin aging.
Modulates inflammaging pathways and senescence-associated secretory phenotype to slow age-related skin deterioration at the cellular level.
Stimulates laminin and nidogen production at the dermal-epidermal junction, strengthening structural integrity and barrier resilience.
Amino Acid Sequence
Dosing
How muchdo I take?
Topical: Applied onto the skin as a cream, gel, or lotion — it works mainly where you put it.
Bioavailability Local — acts mainly at the skin; little reaches the bloodstream.
Starting Dose
Under 10 ppm (<0.001%) in finished product
Frequency
Once or twice daily
Duration
Ongoing
Customary leave-on cosmetic use is below 10 ppm of the active peptide [6]. Pal-GQPR is almost always used as a co-active alongside Pal-GHK in the Matrixyl 3000 blend rather than on its own.
Standard Dose
~3% trade solution (Matrixyl 3000 blend)
Twice daily
~2 months
In manufacturer clinical testing the trade-solution blend was applied twice daily for about two months [6]. The ~3% figure refers to the diluted trade solution, which contains only ppm-level active peptide.
Timing
Best time to take
Apply Palmitoyl Tetrapeptide-7 to clean, dry skin. For best results, use consistently at the same time(s) each day. Evening application is often preferred to allow overnight absorption, unless otherwise directed.
With food?
As a topical product, Palmitoyl Tetrapeptide-7 is not affected by food intake. Apply to clean skin and allow adequate absorption time before covering the area.
If stacking
Palmitoyl Tetrapeptide-7 should be used as directed by your healthcare provider. If combining with other medications or supplements, discuss potential interactions with your provider. Avoid combining with compounds that have overlapping mechanisms unless specifically guided by a medical professional.
Adjusting Your Dose
Increase if
+You've tolerated the current dose for the recommended period without significant side effects
+Therapeutic goals haven't been met at the current dose level
+Your healthcare provider recommends dose escalation based on your response
+Lab work or clinical assessments support a higher dose
Decrease if
-Side effects are bothersome or impacting daily life despite management strategies
-You experience any signs of an adverse reaction
-Lab results indicate the need for dose reduction
-Your healthcare provider recommends a lower dose based on your response
Signs of right dose
✓Therapeutic goals being met with minimal side effects
✓Stable and consistent response to treatment
✓Lab values or clinical markers trending in the right direction
✓Good tolerance with manageable or absent side effects
Dosing Calculator
Calculate Your Exact Dose
Step 1: Peptide Weight
Find the weight printed on your peptide vial label
Look here!
The peptide weight is printed on the label
The weight is on the label
Select Weight
Look for a number followed by 'mg' on the vial label (e.g., 5mg, 10mg)
Suitability
Is thisright for me?
Best For
Individuals with aging skin showing signs of chronic low-grade inflammation
Palmitoyl Tetrapeptide-7 is particularly well-suited for individuals focused on individuals with aging skin showing signs of chronic low-grade inflammation. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Those seeking to reduce UV-damage-related skin aging (photoaging)
Palmitoyl Tetrapeptide-7 is particularly well-suited for individuals focused on those seeking to reduce uv-damage-related skin aging (photoaging). Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
People looking for synergistic peptide therapy in Matrixyl 3000 products
Palmitoyl Tetrapeptide-7 is particularly well-suited for individuals focused on people looking for synergistic peptide therapy in matrixyl 3000 products. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Individuals with sensitive or reactive skin benefiting from anti-inflammatory peptides
Palmitoyl Tetrapeptide-7 is particularly well-suited for individuals focused on individuals with sensitive or reactive skin benefiting from anti-inflammatory peptides. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Consider Alternatives If
Goal: Alternative approaches for cosmetic support
Consider: Consult your healthcare provider for alternatives to Palmitoyl Tetrapeptide-7 based on your specific needs and medical history
Goal: Alternative cosmetic peptides
Consider: GHK-Cu (Copper Peptide), Argireline (Acetyl Hexapeptide-3), Matrixyl (Palmitoyl Pentapeptide-4)
Goal: Non-peptide cosmetic approaches
Consider: Retinol/Retinoids, Hyaluronic acid serums, Vitamin C serums
Who Should Avoid
Do not use if
×Known hypersensitivity to palmitoyl tetrapeptide-7 or formulation excipients
×Active skin infections at the application site
×Severely compromised skin barrier with active inflammation requiring medical intervention
×No known systemic contraindications at cosmetic concentrations
Use with caution if
!You are taking other medications—discuss potential interactions with your healthcare provider
!You have a history of liver or kidney disease
!You are elderly or have multiple medical conditions
!You are planning surgery in the near future—inform your surgeon about Palmitoyl Tetrapeptide-7 use
!You have any chronic health conditions that require regular monitoring
Not Sure?
Compare Palmitoyl Tetrapeptide-7 with similar peptides to find the best fit for your goals.
Administration
How do Iuse it?
Reconstitution
What you need
•Palmitoyl Tetrapeptide-7 in its prescribed form
•Clean, dry storage container
•Measuring device if applicable (oral syringe, measuring cup)
•Calendar or reminder app for dosing schedule
Example
Palmitoyl Tetrapeptide-7 comes in pre-measured doses or forms. Follow the exact dosing instructions on your prescription label. No reconstitution or mixing is typically required for this formulation.
Use Palmitoyl Tetrapeptide-7 exactly as prescribed. Each unit contains the labeled amount. Your healthcare provider will determine the appropriate dose based on your individual needs and response.
Injection
Route
Palmitoyl Tetrapeptide-7 is administered Topical—no injection required
Best sites
•Not applicable—this is not an injectable formulation
Technique
1.Follow the specific administration instructions for your Palmitoyl Tetrapeptide-7 formulation
2.Take or apply as directed by your healthcare provider
3.Store properly between uses according to package instructions
Storage
Before reconstitution
Store Palmitoyl Tetrapeptide-7 in the refrigerator at 36-46°F (2-8°C) in its original packaging. Protect from light and moisture. Do not freeze. Check the expiration date before use. Some formulations may be stored at room temperature for limited periods—check your specific product labeling.
After reconstitution
Once reconstituted, Palmitoyl Tetrapeptide-7 should be kept refrigerated at 36-46°F (2-8°C) and used within the timeframe specified on your product labeling (typically 14-28 days). Label the vial with the reconstitution date. Do not use if the solution appears cloudy, discolored, or contains particles.
Signs of degradation
Solution appears cloudy, discolored, or contains visible particles (should be clear)
Product has been exposed to temperatures outside the recommended storage range
Product has been frozen (unless specifically designed for freeze-thaw stability)
Expiration date has passed or reconstituted solution has exceeded its use-by date
Unusual odor, color change, or visible contamination
Sample Daily Schedule
As prescribed (once daily)
As prescribed by your healthcare provider injection
Site: Topical—rotate sites if applicable
Maintain a consistent schedule for optimal results with Palmitoyl Tetrapeptide-7. Set reminders if needed. If you miss a dose, follow your healthcare provider's instructions—do not double up on doses to compensate.
Safety
Is itsafe?
Safety Profile
Palmitoyl tetrapeptide-7 (Eyeliss) shows excellent safety for periocular use with minimal irritation potential (Draize score <0.5 at 2% concentration). No serious adverse events in cosmetic formulations used for 15+ years. Eye irritation testing per OECD 404 confirms safety; no systemic toxicity in repeat-dose oral studies. Mild local effects limited to topical application site with no dermal penetration.
Clinical efficacy measured through non-invasive imaging (ultrasound, photography analysis) demonstrates edema reduction in periocular area with 25-40% visible improvement in eye puffiness after 4 weeks application. Lymphatic circulation enhancement quantified through fluorescence microlymphography studies. Safety dermatology panel testing confirms ISO 10993 biocompatibility with no irritation at concentrations up to 3%.
Common Side Effects
Experienced by some users
Mild Redness
Temporary mild redness at application site in sensitive individuals. Generally self-resolving within 15-30 minutes.
Management: Perform patch test before first use. If persistent, reduce application frequency.
Slight Tingling
Brief tingling sensation upon application, particularly on skin with compromised barrier.
Management: Normal response for active peptides. Should subside quickly. Ensure skin barrier is intact.
Mild Irritation with Other Actives
Potential for additive mild irritation when layered with multiple active ingredients simultaneously.
Management: Simplify skincare routine. Apply peptide products separately from retinoids or strong acids.
Dryness
Occasional dryness when combined with drying formulations or in very arid environments.
Management: Follow peptide serum with a hydrating moisturizer to seal in benefits.
Less Common
•Allergic Contact Dermatitis
These typically resolve with continued use or dose adjustment.
Stop and Seek Help If
×Severe or worsening side effects that don't improve with dose adjustment or supportive care
×Signs of an allergic reaction—rash, hives, swelling, or difficulty breathing
×Your healthcare provider recommends discontinuation based on your clinical response
×Development of any new medical condition that may be contraindicated with Palmitoyl Tetrapeptide-7
×Pregnancy or planning to become pregnant (unless specifically approved for use during pregnancy)
×Abnormal lab results or clinical markers that suggest adverse effects
Palmitoyl Tetrapeptide-7 should only be started, adjusted, or discontinued under medical supervision. This information is for educational purposes only and does not replace professional medical advice. Never stop a prescribed treatment without consulting your healthcare provider first, as abrupt discontinuation may have consequences.
Interactions
With other peptides
✓May be used together under medical guidance.
With medications
!Strong Chemical Peels - Use with caution—discuss with your healthcare provider.
!High-Concentration Retinoids (initially) - Use with caution—discuss with your healthcare provider.
!Strong Oxidizing Agents - Use with caution—discuss with your healthcare provider.
With supplements
✓Multivitamins - Generally safe to take alongside Palmitoyl Tetrapeptide-7. Space doses apart if taking oral formulations to ensure optimal absorption.
✓Electrolyte supplements - Helpful if experiencing any GI side effects that could lead to dehydration. Safe to combine.
Effectiveness
Does itwork?
Evidence Level
Limited human trials
What to Expect
Weeks 1-4
What you might notice
•Anti-inflammatory signaling begins reducing IL-6 levels in skin
•Early improvements in skin calmness and reduced reactivity
•Skin texture may feel smoother and more even
What's normal
•Full integration of Palmitoyl Tetrapeptide-7 into physiological systems is established
•Long-term Palmitoyl Tetrapeptide-7 response remains personalized to your physiology
•Palmitoyl Tetrapeptide-7 tolerance is well-maintained with consistent dosing
What's next
→Maintain your established Palmitoyl Tetrapeptide-7 protocol for sustained benefits
→Continue periodic monitoring to confirm Palmitoyl Tetrapeptide-7 efficacy
→Review comprehensive Palmitoyl Tetrapeptide-7 response with your provider
Weeks 4-12
•Sustained reduction in inflammaging markers
•Improvements in skin tone and reduced redness from chronic inflammation
•Laminin and nidogen production enhance dermal-epidermal junction integrity
•Palmitoyl Tetrapeptide-7 is now achieving steady-state pharmacokinetics
•Measurable changes aligned with Palmitoyl Tetrapeptide-7's mechanism may appear
•Initial adjustment effects typically resolve by this point
→Maintain Palmitoyl Tetrapeptide-7 dosing exactly as established
→Track progress toward intended outcomes in detail
→Review lab work or biomarker changes with your healthcare team
Weeks 12-24+
•Cumulative anti-inflammatory benefits produce visible improvements in skin firmness and resilience
•When combined with Palmitoyl Tripeptide-1, comprehensive anti-aging results including wrinkle reduction and improved elasticity
•Full therapeutic effects of Palmitoyl Tetrapeptide-7 are well-characterized at this point
•Maintenance of Palmitoyl Tetrapeptide-7's therapeutic effects is typical
•Tolerance patterns with Palmitoyl Tetrapeptide-7 are generally stable over months
→Comprehensive assessment of Palmitoyl Tetrapeptide-7 efficacy should be conducted
→Discuss long-term continuation, cycling, or protocol modifications
→Continue regular monitoring of relevant biomarkers or symptoms
Signs It's Working
Treatment Response
✓Improvement in the primary symptoms or condition being treated
✓Positive changes in relevant lab values or clinical markers
✓Consistent, stable response to Palmitoyl Tetrapeptide-7 over time
✓Reduction in symptom frequency or severity
General Well-being
✓Improved energy levels and daily functioning
✓Better quality of life related to the treated condition
✓Manageable or absent side effects indicating good tolerance
✓Positive feedback from healthcare provider during check-ups
Not Seeing Results?
Common reasons
•Not at therapeutic dose yet—initial doses are for building tolerance, not maximum effect
•Insufficient time at target dose—most compounds need several weeks to show full benefits
•Inconsistent dosing schedule—regular, consistent use is crucial for optimal results
•Individual variation in response—genetics, metabolism, and other factors affect outcomes
•Underlying conditions or medications interfering with absorption or effectiveness
•Improper storage leading to degraded product—always verify proper storage conditions
Key Research
[1]"Senescence-associated secretory phenotype and inflammaging: perspectives of peptide regulation"
Khavinson V, et al., 2022
Finding: A review examined senescence-associated secretory phenotype in cardiovascular cells, where vasoprotective peptides regulate synthesis of anti-aging molecules. Peptide regulation offers prospects for age-associated cardiovascular disease treatment.
[2]"Anti-inflammatory bioactive peptide alleviates skin inflammation by inhibiting the NF-κB signaling pathway"
Guo Z, et al., 2025
Finding: A novel anti-inflammatory peptide from yak bone collagen reduced inflammatory cytokines by 22-40% in DNCB-induced skin inflammation models. The peptide inhibited NF-κB pathway phosphorylation and restored healthy skin microbiota.
[3]"Key molecular regulators in skin regeneration: PPARG, VEGFA, BGLAP, and IL6"
Tolentino JC, et al., 2026
Finding: No abstract available for comprehensive analysis.
[4]"Acetyl Hexapeptide-8 in cosmeceuticals — a review of skin permeability and efficacy"
Zdrada-Nowak J, et al., 2025
Finding: A comprehensive review of acetyl hexapeptide-8 highlighted botox-like wrinkle reduction through neuromuscular modulation. Advanced formulations using emulsions showed improved delivery while maintaining efficacy.
[5]"Current approaches in cosmeceuticals: peptides, biotics and marine biopolymers"
Badilli U, et al., 2025
Finding: Peptides in cosmeceuticals enhance fibroblast proliferation and collagen synthesis while improving skin barrier function and reducing pigmentation. Marine polysaccharides combined with peptides offer natural cosmetic formulations.
[6]"Safety Assessment of Tripeptide-1, Palmitoyl Tripeptide-1, and Related Palmitoyl Peptides as Used in Cosmetics"
Johnson W et al., Cosmetic Ingredient Review (CIR) Expert Panel, 2018
Finding: CIR review covering Palmitoyl Tetrapeptide-7 (Pal-GQPR), a component of Matrixyl 3000; customary leave-on use below 10 ppm, with manufacturer clinical testing twice daily for ~2 months.
The Science
Stacking & Combinations
Frequently Asked Questions